Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 50

1.

Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes.

Redon J, Pichler G; Missed Dose Study Group.

J Hypertens. 2016 Feb;34(2):359-67. doi: 10.1097/HJH.0000000000000793.

PMID:
26867060
2.

Effects of blood transfusion on exercise capacity in thalassemia major patients.

Benedetto D, Rao CM, Cefalù C, Aguglia DO, Cattadori G, D'Ascola DG, Benedetto FA, Agostoni P, Sciomer S.

PLoS One. 2015 May 26;10(5):e0127553. doi: 10.1371/journal.pone.0127553. eCollection 2015.

3.

Accessory mitral valve: a rare cause of asymptomatic severe left ventricular outflow tract obstruction.

Rao CM, Lucà F, Benedetto FA, Benedetto D, Parise O, Gelsomino S.

Ann Thorac Cardiovasc Surg. 2014;20 Suppl:742-5. doi: 10.5761/atcs.cr.13-00109. Epub 2013 Nov 8.

4.

eNOS and caveolin-1 gene polymorphisms interaction and intima media thickness: a proof of concept study in ESRD patients.

Testa A, Spoto B, Sanguedolce MC, Parlongo RM, Pisano A, Tripepi G, Benedetto FA, Mallamaci F, Zoccali C.

Am J Hypertens. 2012 Jan;25(1):103-8. doi: 10.1038/ajh.2011.178. Epub 2011 Oct 6.

PMID:
21976276
5.

Neuropeptide Y receptor Y2 gene polymorphism interacts with plasma neuropeptide Y levels in predicting left ventricular hypertrophy in dialysis patients.

Testa A, Mallamaci F, Macrì R, Pisano A, Spoto B, Malatino LS, Stancanelli B, Tripepi G, Benedetto FA, Zoccali C.

J Hypertens. 2010 Aug;28(8):1745-51. doi: 10.1097/HJH.0b013e32833bd21b.

PMID:
20543711
6.

Detection of pulmonary congestion by chest ultrasound in dialysis patients.

Mallamaci F, Benedetto FA, Tripepi R, Rastelli S, Castellino P, Tripepi G, Picano E, Zoccali C.

JACC Cardiovasc Imaging. 2010 Jun;3(6):586-94. doi: 10.1016/j.jcmg.2010.02.005.

7.

Vitamin D receptor (VDR) gene polymorphism is associated with left ventricular (LV) mass and predicts left ventricular hypertrophy (LVH) progression in end-stage renal disease (ESRD) patients.

Testa A, Mallamaci F, Benedetto FA, Pisano A, Tripepi G, Malatino L, Thadhani R, Zoccali C.

J Bone Miner Res. 2010 Feb;25(2):313-9. doi: 10.1359/jbmr.090717.

8.

Soluble e-selectin is an inverse and independent predictor of left ventricular wall thickness in end-stage renal disease patients.

Stancanelli B, Malatino LS, Cataliotti A, Bellanuova I, Mallamaci F, Tripepi G, Benedetto FA, Leonardis D, Fatuzzo P, Rapisarda F, Zoccali C.

Nephron Clin Pract. 2010;114(1):c74-80. doi: 10.1159/000252806. Epub 2009 Oct 23.

PMID:
19851079
9.

Biomarkers of left atrial volume: a longitudinal study in patients with end stage renal disease.

Tripepi G, Mattace-Raso F, Mallamaci F, Benedetto FA, Witteman J, Malatino L, Zoccali C.

Hypertension. 2009 Oct;54(4):818-24. doi: 10.1161/HYPERTENSIONAHA.109.136804. Epub 2009 Jul 27.

PMID:
19635983
10.

Vascular endothelial growth factor, left ventricular dysfunction and mortality in hemodialysis patients.

Mallamaci F, Benedetto FA, Tripepi G, Cutrupi S, Pizzini P, Stancanelli B, Seminara G, Bonanno G, Rapisarda F, Fatuzzo P, Malatino LS, Zoccali C.

J Hypertens. 2008 Sep;26(9):1875-82. doi: 10.1097/HJH.0b013e328307c3d2.

PMID:
18698224
11.

Rate of atherosclerotic plaque formation predicts cardiovascular events in ESRD.

Benedetto FA, Tripepi G, Mallamaci F, Zoccali C.

J Am Soc Nephrol. 2008 Apr;19(4):757-63. doi: 10.1681/ASN.2007070813. Epub 2008 Jan 9.

12.

Urotensin II and cardiomyopathy in end-stage renal disease.

Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Pizzini P, Cutrupi S, Malatino L.

Hypertension. 2008 Feb;51(2):326-33. Epub 2007 Dec 17.

PMID:
18086953
13.

An additive effect of endothelial nitric oxide synthase gene polymorphisms contributes to the severity of atherosclerosis in patients on dialysis.

Spoto B, Benedetto FA, Testa A, Tripepi G, Mallamaci F, Maas R, Boeger RH, Zoccali C.

Am J Hypertens. 2007 Jul;20(7):758-63.

PMID:
17586410
14.

Left atrial volume monitoring and cardiovascular risk in patients with end-stage renal disease: a prospective cohort study.

Tripepi G, Benedetto FA, Mallamaci F, Tripepi R, Malatino L, Zoccali C.

J Am Soc Nephrol. 2007 Apr;18(4):1316-22. Epub 2007 Mar 14.

15.

Left atrial volume in end-stage renal disease: a prospective cohort study.

Tripepi G, Benedetto FA, Mallamaci F, Tripepi R, Malatino L, Zoccali C.

J Hypertens. 2006 Jun;24(6):1173-80.

PMID:
16685218
16.

Left ventricular systolic function monitoring in asymptomatic dialysis patients: a prospective cohort study.

Zoccali C, Benedetto FA, Tripepi G, Mallamaci F, Rapisarda F, Seminara G, Bonanno G, Malatino LS.

J Am Soc Nephrol. 2006 May;17(5):1460-5. Epub 2006 Apr 5.

17.

The E-selectin gene polymorphism and carotid atherosclerosis in end-stage renal disease.

Testa A, Benedetto FA, Spoto B, Pisano A, Tripepi G, Mallamaci F, Malatino LS, Zoccali C.

Nephrol Dial Transplant. 2006 Jul;21(7):1921-6. Epub 2006 Mar 22.

PMID:
16554320
18.

Atherosclerosis and the Glu298Asp polymorphism of the eNOS gene in white patients with end-stage renal disease.

Spoto B, Benedetto FA, Testa A, Tripepi G, Mallamaci F, Maas R, Boeger RH, Zoccali C, Parlongo RM, Pisano A.

Am J Hypertens. 2005 Dec;18(12 Pt 1):1549-55.

PMID:
16364824
19.

Cardiac consequences of hypertension in hemodialysis patients.

Zoccali C, Benedetto FA, Tripepi G, Mallamaci F.

Semin Dial. 2004 Jul-Aug;17(4):299-303. Review.

PMID:
15250922
20.

Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression.

Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Stancanelli B, Cataliotti A, Malatino LS.

Kidney Int. 2004 Apr;65(4):1492-8.

Supplemental Content

Loading ...
Support Center